UTI E2-Drops
Natural health product licensed in Canada
- Other names
- E2-Kapi, UTI E-Drops Prime, UTIEND, UTIEND-Prime, UTIEND2
- Licence holder
- Natural-E
- NPN or DIN-HM
- 80091554
- Status
- Active licence
- Licence date
- 1 April 2019
- Revision date
- Not provided
- Form
- Liquide
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Conditions légales
Juniperus communis L.: L'étiquetage doit comporter un avertissement recommandant de ne pas utiliser en cas d'insuffisance rénale et un avertissement recommandant de ne pas utiliser de manière prolongée (maximum 6 semaines)
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Juniperus communis Source : Juniperus communis - Fruit Extract : Matériel brut sec Dry plant equivalent : 100 milligramme | 100 mg/ml | Not calculated |
Non-medicinal ingredients
Feuilles d'Origanum vulgare (Origan), Ethanol, Saveur de lavande, Huile Essentielle d'Eucalyptus
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1.5 millilitre | 2 Tous les jours |
Uses authorised in Canada
Traditionally used in Herbal Medicine as a urinary tract antiseptic to help relieve benign urinary tract infections.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you have a kidney disorder.
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist. Consult a health care practitioner if symptoms worsen. Consult a health care practitioner prior to use if you are breastfeeding. Do not use if you are pregnant.
Source
Official Health Canada record, licence 80091554
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.